Nurix Therapeutics, Inc.NRIXNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
9.49%
↑ 132% above average
Average (27q)
-29.89%
Historical baseline
Range
High:161.17%
Low:-457.03%
Volatility
-2068.5%
Relatively stable
| Period | Value |
|---|---|
| Q4 2025 | 9.49% |
| Q3 2025 | -98.83% |
| Q2 2025 | 22.87% |
| Q1 2025 | 3.75% |
| Q4 2024 | -19.60% |
| Q3 2024 | -9.90% |
| Q2 2024 | -7.29% |
| Q1 2024 | 1.04% |
| Q4 2023 | -13.45% |
| Q3 2023 | -52.33% |
| Q2 2023 | 40.40% |
| Q1 2023 | 12.81% |
| Q4 2022 | -2.21% |
| Q3 2022 | -0.68% |
| Q2 2022 | -6.74% |
| Q1 2022 | -12.81% |
| Q4 2021 | -30.75% |
| Q3 2021 | -9.30% |
| Q2 2021 | -8.68% |
| Q1 2021 | -21.90% |
| Q4 2020 | -7.54% |
| Q3 2020 | -344.29% |
| Q2 2020 | 161.17% |
| Q1 2020 | 8.34% |
| Q4 2019 | -457.03% |
| Q3 2019 | 20.89% |
| Q2 2019 | -14.26% |
| Q1 2019 | 0.00% |